CBD Life Sciences Inc. CBDL

Company Overview

CBD Life Sciences Inc. is a publicly traded company operating in the cannabidiol (CBD) and hemp-derived wellness products industry. The company focuses on the development, marketing, and sale of CBD-based consumer products, including tinctures, edibles, capsules, topical products, and pet-related formulations. Public disclosures and OTC market filings indicate that the company primarily targets the health and wellness consumer segment within the broader alternative wellness and nutraceutical markets. Its business model has centered on direct-to-consumer sales and online retail distribution, with additional emphasis on brand development in the U.S. hemp-derived CBD market.

The company evolved from prior business activities before repositioning toward the CBD and cannabis-adjacent wellness sector following changes in U.S. hemp regulation after the 2018 Farm Bill. CBD Life Sciences has used acquisitions, licensing arrangements, and product branding initiatives to expand its product catalog and market visibility. Publicly available information indicates that the company has pursued a strategy focused on low-overhead product commercialization and investor-facing expansion efforts. Data regarding sustained profitability, material market share, or large-scale distribution partnerships remains limited in publicly available filings and disclosures.